Ergot and Oxytocin During Cesarean Delivery Following Failure to Progress in Labour

NCT00481533 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

47

Enrollment

OTHER

Sponsor class

Conditions

Blood Loss, Surgical

Interventions

DRUG: Methyl-Ergonovine-Oxytocin
DRUG: Oxytocin

Sponsor

Samuel Lunenfeld Research Institute, Mount Sinai Hospital